Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
Yesterday, the Senate passed HR 1 in a 51-50 vote, with Senators Collins, Tillis, and Paul voting no and Vice President Vance casting the tie-breaking vote. In the final wraparound amendment, we successfully: While these changes reflect our collective advocacy, make no mistake: HR 1 remains a deeply harmful bill—for Westchester, for New York, and […]
The Business Council of Westchester (BCW) hosted its exclusive VIP Member Summer Reception on Tuesday at the Trump National Golf Club Westchester in Briarcliff Manor. The elegant gathering brought together approximately 125 guests for an evening of networking and connection amid the stunning Trump National Golf Club Westchester. Attendees enjoyed the club’s renowned five-star private […]
BCW Member Community Housing Innovations (CHI), a nonprofit dedicated to housing solutions, will be offering practical and financial assistance to first-time home buyers at its 2025 Homeownership Expo to be held tomorrow at the Sonesta Hotel in White Plains from 11 am to 3 pm. Prospective homeowners or those who already own a home but […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.